Apoptosis following myocardial infarction: Cardiomyocytes and beyond - comment on the paper 'Dynamics of serum-induced endothelial cell apoptosis in patients with myocardial Infarction' by Forteza et al.

European Journal of Clinical Investigation

Volumn 44, Issue 1, 2014, Pages 1-3

  Roubille, François ^a,b   Barrére Lemaire, Stéphanie ^c  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b MONTREAL HEART INSTITUTE   (Canada)

^c INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOPLASTY; APOPTOSIS; EDITORIAL; ENDOTHELIUM CELL; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; INFLAMMATORY CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPERFUSION INJURY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

APOPTOSIS; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; SERUM;

EID: 84890793786     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12188     Document Type: Editorial

References (18)

1. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110:e82-292.
2. Taylor J. 2012 ESC Guidelines on acute myocardial infarction (STEMI). Eur Heart J 2012;33:2501-2.
3. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007;357:1121-35.
4. Roubille F, Combes S, Leal-Sanchez J, Barrere C, Cransac F, Sportouch-Dukhan C et al. Myocardial expression of a dominant-negative form of Daxx decreases infarct size and attenuates apoptosis in an in vivo mouse model of ischemia/reperfusion injury. Circulation 2007;116:2709-17.
5. Vincent A, Gahide G, Sportouch-Dukhan C, Covinhes A, Franck-Miclo A, Roubille F et al. Down-regulation of the transcription factor ZAC1 upon pre- and postconditioning protects against I/R injury in the mouse myocardium. Cardiovasc Res 2012;94:351-8.
6. Zak R. Development and proliferative capacity of cardiac muscle cells. Circ Res 1974;35(Suppl. 2):17-26.
7. Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 2003;108:1395-403.
8. Roubille F, Busseuil D, Merlet N, Kritikou E, Rhéaume E, Tardif J-C. Investigational drugs targeting cardiac fibrosis. Expert Rev Cardiovasc Ther 2013 In press.
9. Dignat-George F, Blann A, Sampol J. Circulating endothelial cells in acute coronary syndromes. Blood 2000;95:728.
10. Bonello L, Laine M, Baumstarck K, Fernandez J, Maillard L, Peyrol M et al. A randomized trial of platelet reactivity monitoring-adjusted clopidogrel therapy versus prasugrel therapy to reduce high on-treatment platelet reactivity. Int J Cardiol 2013;168:4244-8.
11. Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 2004;62:74-85.
12. Roubille F, Franck-Miclo A, Covinhes A, Lafont C, Cransac F, Combes S et al. Delayed postconditioning in the mouse heart in vivo. Circulation 2011;124:1330-6.
13. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet 2013;381:166-75.
14. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011;57:891-903.
15. Kang KT, Coggins M, Xiao C, Rosenzweig A, Bischoff J. Human vasculogenic cells form functional blood vessels and mitigate adverse remodeling after ischemia reperfusion injury in rats. Angiogenesis 2013;16:773-84.
16. Galaup A, Gomez E, Souktani R, Durand M, Cazes A, Monnot C et al. Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4. Circulation 2012;125:140-9.
17. Tardif JC, Tanguay JF, Wright SS, Duchatelle V, Petroni T, Gregoire JC et al. Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial. J Am Coll Cardiol 2013;61:2048-55.
18. Garcia-Dorado D, Andres-Villarreal M, Ruiz-Meana M, Inserte J, Barba I. Myocardial edema: a translational view. J Mol Cell Cardiol 2012;52:931-9.